LSM1 downregulation is involved in prostate cancer progression [27], whereas amplification of the LSM1 gene in luminal BC is significantly related to poor clinical outcome [42] and LSM1 expression was significantly related to tumor stage in BC [31]. The gene discussed is LSM1; the disease is prostate carcinoma.